Novo - Wegovy Tracker: Starter Scrips Still Growing
Another week, another strong performance from Wegovy on the scrips. We now have Wegovy volume data through to 24th February and despite a slowdown in the starter scrips to the 17th, they have picked up again, confounding our expectations of an imminent peak. Whilst we still do expect a peak to the starter scrips in the near term, every week it beats our expectations adds further evidence to our argument that consensus is far too low on Wegovy expectations for 2023 and that Novo will need to upgrade guidance at Q1. Click [HERE] to read our note explaining how Wegovy could hit $5bn this year. We retain our $4bn Wegovy forecast for 2023 given the risks to supply but believe that Novo can sell everything they make this year given that European launches haven’t even started yet.For access to the full report, please contact Naresh Chouhan ( )
Provided by our team of experienced analysts, our work is idea driven, based on independence of thought, sector expertise, and firmly focussed on fundamentals and valuation.
New Street Research is an independent, partner-owned, research firm specialising in equity and debt research. Our equity research embraces the following sectors:
- Pan European Telecom Services and Cable
- US Telecoms, Cable, Satellite and Towers
- Global Emerging Market Telecoms
- Japan Telecoms
- Asian Internet
- Pan European Healthcare
- Global healthcare thematic research
We provide debt research on:
- Pan European Telecom Services and Cable
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.